tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine

C69H91BClN17O8 — CID 159346029

IUPACtert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine
SMILESCC(C)(C)OC(=O)N1CC[C@@H](CC(=O)c2cn(C(C)(C)C)nn2)c2ccc(B3OC(C)(C)C(C)(C)O3)cc2C1.CC1C=C(Nc2nccc(Cl)n2)C=N1.Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C(=O)OC(C)(C)C)CC[C@H]4CC(=O)c3cn(C(C)(C)C)nn3)n2)cn1
InChIInChI=1S/C31H39N9O3.C29H43BN4O5.C9H9ClN4/c1-30(2,3)40-19-26(36-37-40)27(41)15-20-11-13-39(29(42)43-31(4,5)6)17-22-14-21(8-9-24(20)22)25-10-12-32-28(35-25)34-23-16-33-38(7)18-23;1-26(2,3)34-18-23(31-32-34)24(35)16-19-13-14-33(25(36)37-27(4,5)6)17-20-15-21(11-12-22(19)20)30-38-28(7,8)29(9,10)39-30;1-6-4-7(5-12-6)13-9-11-3-2-8(10)14-9/h8-10,12,14,16,18-20H,11,13,15,17H2,1-7H3,(H,32,34,35);11-12,15,18-19H,13-14,16-17H2,1-10H3;2-6H,1H3,(H,11,13,14)/t20-;19-;/m00./s1
InChIKeyLGSVBBSEBFGWBG-DPLATRMDSA-N
MW1332.86 g/mol
LogP12.19
Rot. Bonds12

About tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine

tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine (PubChem CID 159346029) has the molecular formula C69H91BClN17O8 and a molecular weight of 1332.86 g/mol. Its IUPAC name is tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine.

Molecular Properties

Compound Nametert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine
PubChem CID159346029
Molecular FormulaC69H91BClN17O8
Molecular Weight1332.86 g/mol
Exact Mass1331.70
IUPAC Nametert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine
SMILESCC(C)(C)OC(=O)N1CC[C@@H](CC(=O)c2cn(C(C)(C)C)nn2)c2ccc(B3OC(C)(C)C(C)(C)O3)cc2C1.CC1C=C(Nc2nccc(Cl)n2)C=N1.Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C(=O)OC(C)(C)C)CC[C@H]4CC(=O)c3cn(C(C)(C)C)nn3)n2)cn1
InChIInChI=1S/C31H39N9O3.C29H43BN4O5.C9H9ClN4/c1-30(2,3)40-19-26(36-37-40)27(41)15-20-11-13-39(29(42)43-31(4,5)6)17-22-14-21(8-9-24(20)22)25-10-12-32-28(35-25)34-23-16-33-38(7)18-23;1-26(2,3)34-18-23(31-32-34)24(35)16-19-13-14-33(25(36)37-27(4,5)6)17-20-15-21(11-12-22(19)20)30-38-28(7,8)29(9,10)39-30;1-6-4-7(5-12-6)13-9-11-3-2-8(10)14-9/h8-10,12,14,16,18-20H,11,13,15,17H2,1-7H3,(H,32,34,35);11-12,15,18-19H,13-14,16-17H2,1-10H3;2-6H,1H3,(H,11,13,14)/t20-;19-;/m00./s1
InChIKeyLGSVBBSEBFGWBG-DPLATRMDSA-N
XLogP12.19
TPSA278.90 Ų
H-Bond Donors2
H-Bond Acceptors23
Rotatable Bonds12
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001332.86
LogP ≤ 512.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine?
The IUPAC name of tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine (CID 159346029) is tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine.
What is the SMILES notation for tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine?
The canonical SMILES for tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine is CC(C)(C)OC(=O)N1CC[C@@H](CC(=O)c2cn(C(C)(C)C)nn2)c2ccc(B3OC(C)(C)C(C)(C)O3)cc2C1.CC1C=C(Nc2nccc(Cl)n2)C=N1.Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C(=O)OC(C)(C)C)CC[C@H]4CC(=O)c3cn(C(C)(C)C)nn3)n2)cn1.
What is the InChIKey of tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine?
The InChIKey is LGSVBBSEBFGWBG-DPLATRMDSA-N. The full InChI is InChI=1S/C31H39N9O3.C29H43BN4O5.C9H9ClN4/c1-30(2,3)40-19-26(36-37-40)27(41)15-20-11-13-39(29(42)43-31(4,5)6)17-22-14-21(8-9-24(20)22)25-10-12-32-28(35-25)34-23-16-33-38(7)18-23;1-26(2,3)34-18-23(31-32-34)24(35)16-19-13-14-33(25(36)37-27(4,5)6)17-20-15-21(11-12-22(19)20)30-38-28(7,8)29(9,10)39-30;1-6-4-7(5-12-6)13-9-11-3-2-8(10)14-9/h8-10,12,14,16,18-20H,11,13,15,17H2,1-7H3,(H,32,34,35);11-12,15,18-19H,13-14,16-17H2,1-10H3;2-6H,1H3,(H,11,13,14)/t20-;19-;/m00./s1.
What are the key properties of tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine?
tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine has a molecular weight of 1332.86 g/mol, XLogP of 12.19, 12 rotatable bonds, 2 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;tert-butyl (5S)-5-[2-(1-tert-butyltriazol-4-yl)-2-oxoethyl]-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;4-chloro-N-(2-methyl-2H-pyrrol-4-yl)pyrimidin-2-amine is sourced from PubChem (CID 159346029), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).